Targeting erythroblast-specific apoptosis in experimental anemia

Apoptosis

Volumn 13, Issue 8, 2008, Pages 1022-1030

  Diwan, Abhinav ^a,b,c   Koesters, Andrew G ^a   Capella, Devan ^a   Geiger, Hartmut ^d   Kalfa, Theodosia A ^d   Dorn II, Gerald W ^a,c,d  

^a UNIVERSITY OF CINCINNATI   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Anemia; Apoptosis; Erythropoiesis; Erythropoietin

Indexed keywords

ERYTHROPOIETIN; PHENYLHYDRAZINE;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROCYTE; ERYTHROPOIESIS; HEMATOCRIT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANEMIA; ANIMALS; APOPTOSIS; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ERYTHROBLASTS; ERYTHROCYTE COUNT; ERYTHROCYTES; ERYTHROPOIETIN; GENE TARGETING; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MITOCHONDRIAL PROTEINS; OXIDANTS; PHENYLHYDRAZINES; RECOVERY OF FUNCTION;

MUS;

EID: 47349088628     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-008-0236-3     Document Type: Article

References (48)

1. H Wu X Liu R Jaenisch HF Lodish 1995 Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor Cell 83 59 67 10.1016/0092-8674(95)90234-1
2. Italian Cooperative Study Group for rHuEpo in Myelodysplastic Syndromes 1998 A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes Br J Haematol 103 1070 107 10.1046/j.1365-2141.1998.01085.x
3. B Blumenauer A Cranney J Clinch P Tugwell 2003 Quality of life in patients with rheumatoid arthritis: which drugs might make a difference? Pharmacoeconomics 21 927 940 10.2165/00019053-200321130-00002
4. TJ Littlewood D Cella JW Nortier 2002 Erythropoietin improves quality of life Lancet Oncol 3 459 460 10.1016/S1470-2045(02)00827-6
5. JW Eschbach JC Egrie MR Downing JK Browne JW Adamson 1987 Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial N Engl J Med 316 73 78
6. HL Corwin A Gettinger TC Fabian 2007 Efficacy and safety of epoetin alfa in critically ill patients N Engl J Med 357 965 976 10.1056/NEJMoa071533
7. R Steinbrook 2007 Erythropoietin, the FDA, and oncology N Engl J Med 356 2448 2451 10.1056/NEJMp078100
8. IC Macdougall 2007 Epoetin-induced pure red cell aplasia: diagnosis and treatment. Curr Opin Nephrol Hypertens 16 585 588 10.1097/MNH.0b013e3282f0c4bf
9. S Fishbane A Besarab 2007 Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets. Clin J Am Soc Nephrol 2 1274 1282 10.2215/CJN.02380607
10. A Phrommintikul SJ Haas M Elsik H Krum 2007 Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis Lancet 369 381 388 10.1016/S0140-6736(07)60194-9
11. C Lacombe 1996 Resistance to erythropoietin N Engl J Med 334 660 662 10.1056/NEJM199603073341012
12. Van Dyke, Layrisse M, Lawrence JH, Garcia JF, Pollycove M (1961) Relation between severity of anemia and erythropoietin titer in human beings. Blood 18:187-201
13. MJ Koury MC Bondurant 1990 Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells Science 248 378 381 10.1126/science.2326648
14. M Socolovsky AE Fallon S Wang C Brugnara HF Lodish 1999 Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction Cell 98 181 191 10.1016/S0092-8674(00)81013-2
15. N Motoyama F Wang KA Roth 1995 Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice Science 267 1506 1510 10.1126/science.7878471
16. MW Kieran AC Perkins SH Orkin LI Zon 1996 Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor Proc Natl Acad Sci USA 93 9126 9131 10.1073/pnas.93.17.9126
17. T Lindsten AJ Ross A King 2000 The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues Mol Cell 6 1389 1399 10.1016/S1097-2765(00)00136-2
18. MC Wei WX Zong EH Cheng 2001 Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292 727 730 10.1126/science.1059108
19. A Diwan AG Koesters AM Odley 2007 Unrestrained erythroblast development in Nix-/- mice reveals a mechanism for apoptotic modulation of erythropoiesis. Proc Natl Acad Sci USA 104 6794 6799 10.1073/pnas.0610666104
20. M Socolovsky H Nam MD Fleming VH Haase C Brugnara HF Lodish 2001 Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts Blood 98 3261 3273 10.1182/blood.V98.12.3261
21. AM Vannucchi L Bianchi C Cellai 2001 Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1(low) mice) Blood 97 3040 3050 10.1182/blood.V97.10.3040
22. MC Giarratana L Kobari H Lapillonne 2005 Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells Nat Biotechnol 23 69 74 10.1038/nbt1047
23. SK Ballas MR Clark N Mohandas 1984 Red cell membrane and cation deficiency in Rh null syndrome Blood 63 1046 1055
24. TA Kalfa S Pushkaran N Mohandas 2006 Rac GTPases regulate the morphology and deformability of the erythrocyte cytoskeleton. Blood 108 3637 3645 10.1182/blood-2006-03-005942
25. A Bauer F Tronche O Wessely 1999 The glucocorticoid receptor is required for stress erythropoiesis Genes Dev 13 2996 3002 10.1101/gad.13.22.2996
26. JY Chan M Kwong M Lo R Emerson FA Kuypers 2001 Reduced oxidative-stress response in red blood cells from p45NFE2-deficient mice Blood 97 2151 2158 10.1182/blood.V97.7.2151
27. C Peschle MC Magli C Cillo 1977 Kinetics of erythroid and myeloid stem cells in post-hypoxia polycythaemia Br J Haematol 37 345 352 10.1111/j.1365-2141.1977.tb01005.x
28. LC Ou D Kim WM Layton Jr RP Smith 1980 Splenic erythropoiesis in polycythemic response of the rat to high-altitude exposure J Appl Physiol 48 857 861
29. RL Schweers J Zhang MS Randall 2007 NIX is required for programmed mitochondrial clearance during reticulocyte maturation. Proc Natl Acad Sci USA 104 19500 19505 10.1073/pnas.0708818104
30. Sandoval H, Thiagarajan P, Dasgupta SK et al (2008) Essential role for Nix in autophagic maturation of erythroid cells. Nature. doi: 10.1038/nature07006
31. M Walsh RJ Lutz TG Cotter R O'Connor 2002 Erythrocyte survival is promoted by plasma and suppressed by a Bak-derived BH3 peptide that interacts with membrane-associated Bcl-X(L) Blood 99 3439 3448 10.1182/blood.V99.9.3439
32. I Brodsky LH Dennis SB Kahn 1966 Erythropoiesis in Friend leukemia: red blood cell survival and ferrokinetics. Cancer Res 26 1887 1892
33. MJ Weiss SH Orkin 1995 Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis Proc Natl Acad Sci USA 92 9623 9627 10.1073/pnas.92.21.9623
34. M Silva D Grillot A Benito C Richard G Nunez JL Fernandez-Luna 1996 Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2 Blood 88 1576 1582
35. T Gregory C Yu A Ma SH Orkin GA Blobel MJ Weiss 1999 GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression Blood 94 87 96
36. G Chen J Cizeau VC Vande 1999 Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins J Biol Chem 274 7 10 10.1074/jbc.274.1.7
37. W Aerbajinai M Giattina YT Lee M Raffeld JL Miller 2003 The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation Blood 102 712 717 10.1182/blood-2002-11-3324
38. LL Kelley MJ Koury MC Bondurant ST Koury ST Sawyer A Wickrema 1993 Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production Blood 82 2340 2352
39. VG Karur CA Lowell P Besmer V Agosti DM Wojchowski 2006 Lyn kinase promotes erythroblast expansion and late-stage development Blood 108 1524 1532 10.1182/blood-2005-09-008243
40. MP Menon V Karur O Bogacheva O Bogachev B Cuetara DM Wojchowski 2006 Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis J Clin Invest 116 683 694 10.1172/JCI25227
41. M Ferrali C Signorini L Ciccoli M Comporti 1992 Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil Biochem J 285 Pt 1 295 301
42. A Bogdanova D Mihov H Lutz B Saam M Gassmann J Vogel 2007 Enhanced erythro-phagocytosis in polycythemic mice overexpressing erythropoietin Blood 110 762 769 10.1182/blood-2006-12-063602
43. F Stohlman Jr 1961 Humoral regulation of erythropoiesis. VII. Shortened survival of erythrocytes produced by erythropoietine or severe anemia Proc Soc Exp Biol Med 107 884 887
44. C Anderson I Aronson P Jacobs 2000 Erythropoiesis: erythrocyte deformability is reduced and fragility increased by iron deficiency Hematology 4 457 460
45. G Barosi M Cazzola F Frassoni E Orlandi M Stefanelli 1981 Erythropoiesis in myelofibrosis with myeloid metaplasia: recognition of different classes of patients by erythrokinetics Br J Haematol 48 263 272
46. NI Berlin JH Lawrence HC Lee 1951 The life span of the red blood cell in chronic leukemia and polycythemia Science 114 385 387 101126/science1142963385
47. RL Huff TG Hennessy RE Austin JF Garcia BM Roberts JH Lawrence 1950 Plasma and red cell iron turnover in normal subjects and in patients having various hematopoietic disorders J Clin Invest 29 1041 1052 10.1172/JCI102335
48. F Syed A Odley HS Hahn 2004 Physiological growth synergizes with pathological genes in experimental cardiomyopathy Circ Res 95 1200 1206 10.1161/01.RES.0000150366.08972.7f